Early clinical results with the neuroleptic roxindole (EMD 49 980) in the treatment of schizophrenia — an open study

Siegfried Kasper, Johannes Fuger, Hans-Jürgen Zinner, Josef Bäuml, Hans-Jürgen Möller
  • European Neuropsychopharmacology, March 1992, Elsevier
  • DOI: 10.1016/0924-977x(92)90041-6
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Hans-Juergen Moeller